Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design.

IF 3 3区 医学 Q1 OPHTHALMOLOGY
José F Alfonso, Luis Fernández-Vega-Cueto, Belén Alfonso-Bartolozzi, Robert Montés-Micó, Luis Fernández-Vega
{"title":"Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design.","authors":"José F Alfonso,&nbsp;Luis Fernández-Vega-Cueto,&nbsp;Belén Alfonso-Bartolozzi,&nbsp;Robert Montés-Micó,&nbsp;Luis Fernández-Vega","doi":"10.3928/1081597X-20190118-01","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the long-term correction of moderate to high myopia using a posterior chamber phakic intraocular lens with a central port design.</p><p><strong>Methods: </strong>Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, refraction, intraocular pressure (IOP), endothelial cell density (ECD), vault, and adverse events over a 5-year period were evaluated retrospectively.</p><p><strong>Results: </strong>A total of 147 eyes (83 patients) were evaluated. Mean postoperative UDVA and CDVA were 0.05 ± 0.11 and 0.02 ± 0.08 logMAR at 1 year and 0.13 ± 0.18 and 0.02 ± 0.09 logMAR at 5 years, respectively. More than 95% of eyes achieved CDVA of 20/25 or better at both follow-up periods. CDVA was unchanged or improved from one to three or more lines in all eyes. Preoperatively, mean spherical equivalent (SE) was -9.20 ± 3.02 diopters (D). At 1 year, the mean SE was -0.17 ± 0.26 D, with 91.53% of eyes within ±0.50 D and 100% of eyes within ±1.00 D of the target. At 5 years, the mean SE was -0.44 ± 0.47 D, with 67.4% of eyes within ±0.50 D and 90.1% of eyes within ±1.00 D of the target. Mean IOP was 12.74 ± 1.65 and 13.0 ± 2.03 mm Hg, at 1 and 5 years, respectively. No significant rise in IOP (> 20 mm Hg) occurred during the follow-up period. Mean ECD was 2,696 ± 358 and 2,645 ± 359 cells/mm<sup>2</sup> at 1 and 5 years, respectively, representing a non-significant loss of 0.43% from preoperative values (P = .304). Mean vault changed significantly from 398 ± 187 µm at 1 year to 340 ± 163 µm at 5 years (P < .001). No intraoperative or postoperative complications or adverse events occurred during the follow-up period.</p><p><strong>Conclusions: </strong>The good long-term outcomes found in this study support the use of this lens with a central port design for the correction of moderate to high myopia. [J Refract Surg. 2019;35(3):169-176.].</p>","PeriodicalId":16951,"journal":{"name":"Journal of refractive surgery","volume":" ","pages":"169-176"},"PeriodicalIF":3.0000,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"51","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/1081597X-20190118-01","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 51

Abstract

Purpose: To assess the long-term correction of moderate to high myopia using a posterior chamber phakic intraocular lens with a central port design.

Methods: Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, refraction, intraocular pressure (IOP), endothelial cell density (ECD), vault, and adverse events over a 5-year period were evaluated retrospectively.

Results: A total of 147 eyes (83 patients) were evaluated. Mean postoperative UDVA and CDVA were 0.05 ± 0.11 and 0.02 ± 0.08 logMAR at 1 year and 0.13 ± 0.18 and 0.02 ± 0.09 logMAR at 5 years, respectively. More than 95% of eyes achieved CDVA of 20/25 or better at both follow-up periods. CDVA was unchanged or improved from one to three or more lines in all eyes. Preoperatively, mean spherical equivalent (SE) was -9.20 ± 3.02 diopters (D). At 1 year, the mean SE was -0.17 ± 0.26 D, with 91.53% of eyes within ±0.50 D and 100% of eyes within ±1.00 D of the target. At 5 years, the mean SE was -0.44 ± 0.47 D, with 67.4% of eyes within ±0.50 D and 90.1% of eyes within ±1.00 D of the target. Mean IOP was 12.74 ± 1.65 and 13.0 ± 2.03 mm Hg, at 1 and 5 years, respectively. No significant rise in IOP (> 20 mm Hg) occurred during the follow-up period. Mean ECD was 2,696 ± 358 and 2,645 ± 359 cells/mm2 at 1 and 5 years, respectively, representing a non-significant loss of 0.43% from preoperative values (P = .304). Mean vault changed significantly from 398 ± 187 µm at 1 year to 340 ± 163 µm at 5 years (P < .001). No intraoperative or postoperative complications or adverse events occurred during the follow-up period.

Conclusions: The good long-term outcomes found in this study support the use of this lens with a central port design for the correction of moderate to high myopia. [J Refract Surg. 2019;35(3):169-176.].

近视矫正的5年随访:中心孔设计的后房型有晶状体人工晶体。
目的:评价中心孔设计的后房型有晶状体人工晶状体对中高度数近视的长期矫正效果。方法:回顾性评价5年期间未矫正(UDVA)和矫正(CDVA)的距离、屈光、眼内压(IOP)、内皮细胞密度(ECD)、拱顶和不良事件。结果:共检查147只眼(83例)。术后1年平均UDVA和CDVA分别为0.05±0.11和0.02±0.08 logMAR, 5年平均UDVA和CDVA分别为0.13±0.18和0.02±0.09 logMAR。在两个随访期间,95%以上的眼睛的CDVA达到20/25或更好。所有眼的CDVA从一条线到三条线或多条线不变或改善。术前平均球等效度(SE)为-9.20±3.02屈光度(D), 1年时平均SE为-0.17±0.26 D, 91.53%的眼在±0.50 D范围内,100%的眼在±1.00 D范围内。5年时,平均SE为-0.44±0.47 D, 67.4%的眼睛在±0.50 D内,90.1%的眼睛在±1.00 D内。1年和5年的平均IOP分别为12.74±1.65和13.0±2.03 mm Hg。随访期间眼压未明显升高(> 20 mm Hg)。1年和5年的平均ECD分别为2,696±358和2,645±359个细胞/mm2,较术前值无显著性损失0.43% (P = .304)。平均拱顶从1年的398±187µm显著增加到5年的340±163µm (P < 0.001)。随访期间无术中、术后并发症及不良事件发生。结论:本研究中发现的良好的长期效果支持使用这种具有中心孔设计的晶状体来矫正中至高度近视。[J].中华眼科杂志,2019;35(3):169-176。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.10
自引率
12.50%
发文量
160
审稿时长
4-8 weeks
期刊介绍: The Journal of Refractive Surgery, the official journal of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology, has been a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures for more than 30 years. Practical, clinically valuable articles provide readers with the most up-to-date information regarding advances in the field of refractive surgery. Begin to explore the Journal and all of its great benefits such as: • Columns including “Translational Science,” “Surgical Techniques,” and “Biomechanics” • Supplemental videos and materials available for many articles • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信